Juul

van den Reek

,

MD, PhD

Scientific Researcher

Radboud University Medical Center

Nijmegen

Netherlands

2022 Fellow

Councilor Since: March 8, 2024

IPC Councilor

Dr. Juul van den Reek works as an MD/epidemiologist at the Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands, where she combines research with patient care in the specialized psoriasis clinic. Her research interest focuses on clinical epidemiology and, more specifically, evaluating real-world data of patients treated with biologics for inflammatory diseases. She coordinates the BioCAPTURE registry, a national psoriasis registry for biologics, and the BeNeBio consortium, a Dutch-Belgium study on dose reduction of biologics for psoriasis. She is the medical advisor for the Dutch Psoriasis Foundation journal and a Dutch Psoriasis guideline committee member. Dr. van den Reek studied with IPC Board Member Joel Gelfand during her IPC Fellowship at his Philadelphia, Pennsylvania, United States clinic. She has been an IPC Councilor since March 2024.

Last Updated:

03/01/2024

Areas of Interest

Evaluation of effectiveness, drug survival, and safety of biologics for psoriasis in practice (real-world evidence), planetary health and psoriasis (sustainable choices in psoriasis care, including dose reduction of biologics and remote care), epidemiology of psoriasis and its comorbidities, and the Influence of gender on outcomes of psoriasis treatment

IPC Committees / Groups

Editorial Committee, Regional Development Task Force

Languages Spoken

Dutch, English

Involvement with Other Organization(s)

Dr. van den Reek is the Dutch Psoriasis Patient Federation journal advisor. The patient federation is closely involved in Dr. van den Reek’s studies as a patient advisor in her research. In 2017, she was a fellow of the National Psoriasis Foundation (NPF).

Featured

Video

Sex Differences in Psoriasis.

In this Take Ten with IPC video, Juul van den Reek and PhD candidate Liana Barenbrug discuss sex differences in…

Watch Video

PDF

A Report from the 34th Annual European Academy of Dermatology and Venereology (EADV) Congress.

Key takeaways from the 2025 EADV Congress in Paris, including the IPC Symposium on psoriasis, Free Communication…

View Report

PDF

The Global Burden of Pediatric Psoriasis: A Systematic Review.

View Report

PDF

IPC Psoriasis Disease Severity Reclassification: Update on Validity, Acceptance, and Implementation.

View Report

PDF

Investigation of the Applicability of Adult Definitions of Disease Severity for Psoriasis in a Pediatric Cohort: A…

Conflicts of interest Dr Al-Gawahiri carried out clinical trials for Janssen. All funding is not personal but goes to…

View Report

Video

The Epidemiology of Psoriasis.

In this Take Ten with IPC video, Dr. Juul van den Reek discusses the global epidemiology of psoriasis and highlights…

Watch Video

Blog

Shining a Spotlight on our 2022 Fellows: Get to Know the Future Leaders in Psoriasis – Juul van den Reek, MD, PhD.

Learn about Juul van den Reek's experience as a 2022 participant in IPC's International Fellowship Program. In this…

Focus on Psoriasis: A Report from the 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN).

Experts worldwide report on their experiences and deliver insight into the latest results and clinical studies. The…

View Report

Blog

Focus on Psoriasis: A Report from the 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN)…

The 7th Congress of the Skin Inflammation & Psoriasis International Network (SPIN) was held Wednesday, July 6 –…

Focus on Psoriasis: A Report from the 2021 Hybrid Gene to Clinic Congress.

The Psoriasis: from Gene to Clinic International Congress provides a forum for psoriasis experts from around the world…

Focus on Psoriasis – A Report from the 2021 Hybrid Gene to Clinic Congress.

View Report

Load More Show Less

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.

Tuesday, June 23, 2026

Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress

IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.

Monday, June 22, 2026

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Advancing Knowledge. Improving Care.

Juul

van den Reek

,

MD, PhD

Areas of Interest

IPC Committees / Groups

Languages Spoken

Involvement with Other Organization(s)

Quick Links

Follow us

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

Fellow Perspectives | Psoriasis Care in Ethiopia: Challenges and Opportunities for Progress

Videos Now Available from the IPC Symposium at SID Chicago

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Thursday, June 11, 2026